We next assessed modulation of plasma levels of miR-329-5p, identified by reverse target prediction analysis based on its potential to regulate inflammatory and immune mediators (e.g., TLR-4, IL-1 and TNF-related signaling pathways) involved in ischemia and PC. Here, TLR4 is linked to pachyonychia congenita.